🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 00650F109
- Market Cap
- Large Cap · $4 Billion
- IPO
- 6/27/2019 · $20.00/share
Business: Adaptive Biotechnologies Corp. is a commercial-stage biotech company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. The Company's proprietary immune medicine platform reveals and translates the massive genetics of the adaptive immune system with unprecedented scale, precision and speed to develop products in life sciences research, clinical diagnostics, and drug discovery.
Company Contact
- CEO
- Chad Robins
- CFO
- Chad Cohen
- Headquarters
- 1551 Eastlake Avenue East, Suite 200, Seattle, WA 98102
- Phone
- 206-659-0067
- Investor Relations
- Lynn Lewis · 415-937-5405 · investors@adaptivebiotech.com